RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, will be presenting at the SMi Superbugs & Superdrugs Conference – A Focus on Antibacterials. The presentation will be given by PolyMedix Vice President of Drug Development, Dr. Bozena Korczak, on Thursday, March 19, 2009, at 11:00 am.
